Gresner S M, Rieske P, Wozniak K, Piaskowski S, Jaskolski D J, Skowronski W, Golanska E, Sikorska B, Liberski P P
Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Poland.
Clin Neuropathol. 2006 Jan-Feb;25(1):18-24.
Loss of heterozygosity (LOH) on 1p and 19q is observed in most oligodendroglial tumors. LOH on 10q appears to be less common in these tumors as compared to other gliomas.
We reviewed 14 patients with oligodendroglial tumors (10 low-grade and 4 anaplastic oligodendroglioma) to evaluate the frequency of LOH on 1p, 10q and 19q and correlate it with tumor grade and patients' age and gender; 5 loci on 1p and 5 on 19q as well as 4 on 10q were analyzed for LOH using PCR techniques.
LOH on 1p together with 19q was detected in 6 tumors, 1 tumor showed deletion of 19q accompanied with deletion on 10q. Deletion on 1p was associated with deletion of 19q (p < 0.005) and mutual associations among deletions at loci on 19q (p < 0.05) were found. Patients with LOH on 1p were younger on average than patients with retained heterozygosity (p = 0.05). Grade II oligodendrogliomas predominated among younger patients (p < 0.01) while grade III oligodendrogliomas predominated among women (p < 0.005). No association between LOH on 1p nor 19q and tumor grade or patients' gender was found.
Our study provides several clinically interesting findings and further supports the hypothesis of chromosome 1p and 19q involvement in the oligodendroglial cancerogenesis.
在大多数少突胶质细胞瘤中可观察到1p和19q杂合性缺失(LOH)。与其他胶质瘤相比,10q上的LOH在这些肿瘤中似乎不太常见。
我们回顾了14例少突胶质细胞瘤患者(10例低级别和4例间变性少突胶质细胞瘤),以评估1p、10q和19q上LOH的频率,并将其与肿瘤分级、患者年龄和性别相关联;使用PCR技术分析了1p上的5个位点、19q上的5个位点以及10q上的4个位点的LOH情况。
在6例肿瘤中检测到1p与19q同时存在LOH,1例肿瘤显示19q缺失并伴有10q缺失。1p缺失与19q缺失相关(p < 0.005),并且发现19q上各位点缺失之间存在相互关联(p < 0.05)。1p发生LOH的患者平均年龄比杂合性保留的患者年轻(p = 0.05)。II级少突胶质细胞瘤在年轻患者中占主导(p < 0.01),而III级少突胶质细胞瘤在女性中占主导(p < 0.005)。未发现1p或19q上的LOH与肿瘤分级或患者性别之间存在关联。
我们的研究提供了一些临床上有趣的发现,并进一步支持了1号染色体p和19q参与少突胶质细胞肿瘤发生的假说。